ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

New Frederick RFP Out May 14; Five contracts To Be Awarded, Each For Five to Seven Years

May 2, 1986

14 Institutions Awarded $100 Million for AIDS Treatment Evaluation Units

July 4, 1986

House Committee To Examine Personal Genetic Test Kits

May 21, 2010

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

Jury Awards $14 Million To Medenica Patient

February 24, 1995